Oxygenases continue to be widely studied for selective biooxidation of organic compounds.
Introduction
Oxygenases are enzymes which introduce one or two atoms of molecular oxygen into an organic molecule. They are attractive for chemical synthesis and bioremediation as they react with a wide range of organic substances (Figure 1 ). Moreover, oxygenases may be enantio-, chemo-or regioselective and thus can produce optically pure compounds in reactions where chemical catalysts fail. Herein we focus on key papers on oxygenases, published over the past two years, which emphasize practical applications. A number of other reviews in this area have recently been published [1,2, * 3].
Oxygenases are being exploited in various industrial processes [1] . Compared to other industrial enzymes such as hydrolases or isomerases, however, their practical applications are still limited. The major reasons are that most oxygenases are membrane-associated, often not very stable, displaying rather low activity. For their function, most oxygenases require reduction equivalents, which are usually supplied by NADPH or NADH. Besides, they need electron-transfer partners like e.g., flavin reductases and iron-sulfur proteins, which might be also membrane-associated.
Some of these limitations can be overcome by using whole-cell systems. Here, however, physiological effects such as low expression rates, limited substrate uptake, toxicity of substrate or product, and product degradation must be taken into account.
The mainstream of current studies is thus to either engineer isolated oxygenases for altered selectivity or enhanced stability, or to engineer the metabolism of whole cells towards 3 improved yield of the desired oxidation product or to combine both approaches. This applies to hydroxylation and epoxidation reactions, Baeyer-Villiger oxidation and dihydroxylationbiotransformation steps on which this review will be focused.
Monooxygenases: cytochrome P450 monooxygenases
Cytochrome P450 enzymes (CYPs) are heme-containing monooxygenases present in virtually all groups of living organisms. CYPs catalyze monooxygenation of hydrophobic compounds in the presence of NAD(P)H and are a potentially useful class of catalysts as they are able to introduce oxygen even at non-activated carbon-hydrogen bonds. had 4-fold lower reactions rates but were much more selective, forming >85% of (+)-transnoonkatol and (+)-nootkatone.
Selective oxyfunctionalization of inert hydrocarbons is still a challenge for organic chemists.
Arnold and co-workers combined several rounds of directed evolution with protein modeling and site-directed mutagenesis to alter the selectivity of CYP102A1 from hydroxylation of dodecane (C12) first to C8 (octane) and to C6 (hexane) and further on to C3 (propane) and C2 
Non-heme monooxygenases
Non-heme monooxygenases are flavin-containing enzymes. Like P450 monooxygenases they require for activity NAD(P)H. Protein engineering was used to modify enzyme activity, specificity and stability of non-heme monooxygenases. Thus, a new styrene monooxygenase is not sufficient for a technical process and has to be optimized.
Another non-heme monooxygenase, 2-hydroxybiphenyl-3-monooxygenase (HbpA) from
Pseudomonas azelaica HBP1, was engineered by directed evolution to accept a broad range The best studied BVMO is cyclohexanone monooxygenase (CHMO) from Acinetobacter sp. 
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Using directed evolution and an automated GC screening on 10000 mutants, cyclohexanone monooxygenases with enantioselectivity exceeding 90% ee were screened. In this work, variants of CYP102A1 (P450 BM-3) were constructed and described, which are able to accept and convert propranolol, a multi-function beta-adrenergic blocker. 
